학술논문
Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: “Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI).” Schaeverbeke et al. Joint Bone Spine 2018;95:399-402
Document Type
Correspondence
Source
In Joint Bone Spine March 2019 86(2):287-288
Subject
Language
ISSN
1297-319X